Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glial cell-derived neurotrophic factor receptor alpha-like (GFRAL) is a signaling receptor that forms a complex with the RET tyrosine kinase upon binding to its ligand, Growth Differentiation Factor 15 (GDF15). This interaction primarily occurs in neurons of the area postrema and nucleus tractus solitarius in the brainstem and plays a crucial role in appetite regulation and energy homeostasis. As such, GFRAL represents a potential therapeutic target for conditions like obesity, anorexia, and cancer-related cachexia.
GDF15 binding to GFRAL induces RET tyrosine kinase activation, triggering downstream signaling pathways affecting energy balance and feeding behavior.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glial cell-derived neurotrophic factor receptor alpha-like (GFRAL).